Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
SHED at a Glance
- What it is
- The widest medication and format range anywhere — priced by dose, with two different money-back guarantees on the same site
- Medication type
- Brand-name and compounded
- Medications offered
- Compounded semaglutide (injection)
- Compounded tirzepatide (injection)
- Brand-name Wegovy and Zepbound pens
- Foundayo (orforglipron), the daily oral GLP-1
- GLP-1 liquid drops, sublingual lozenges, and a microdose plan
- Non-GLP-1 options: metformin/naltrexone/topiramate, naltrexone/bupropion, MIC+B12
- Pricing
- Compounded semaglutide "from $159/mo" and tirzepatide "from $239/mo" — dose-escalation pricing, so your cost rises as you titrate
- Insurance
- Compounded medication is never covered. SHED does offer brand-name Wegovy and Zepbound, which insurance may cover, though it does not publish an insurance pathway. It confirms FSA eligibility for its GLP-1 products.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is SHED?
SHED, formerly ShedRx, is a telehealth weight-loss platform trading since December 2022 and reporting more than 150,000 members. It is LegitScript-approved, names a prescribing physician publicly in Dr Asad Niazi, MD, and covers more ground than any other provider in this comparison.
The range really is exceptional. Compounded semaglutide and tirzepatide by injection, brand-name Wegovy and Zepbound pens, Foundayo — the daily oral GLP-1 — plus liquid drops, sublingual lozenges and a dedicated microdose plan. Almost nobody offers a compounded route, an FDA-approved route and a needle-free route from the same account. Included with it: unlimited follow-up appointments, health coaching, a tracking app, a nutrition plan and community access. For anyone unsure which format or molecule will suit them, that flexibility is worth something real.
The pricing is where it gets slippery. SHED publishes "from" figures — compounded semaglutide "From $159/mo", compounded tirzepatide "starting as low as $239/mo" — and does not publish a price for its brand-name pens, its lozenges, its drops or Foundayo anywhere we could find. Third-party reporting puts the actual figures higher and describes a dose-escalation model in which your monthly cost rises as your dose does, quoting around $199/month for injections and the Wegovy pen, $299 for compounded semaglutide and $399 for compounded tirzepatide.
Dose-based pricing is the single biggest trap in this market, because a starter-dose quote can bear little relation to what you pay at maintenance. A provider that advertises "from $159" on that model is showing you the least representative number it has.
How the Program Works
- Consultation process
- Online intake reviewed by licensed medical providers, with unlimited follow-up appointments included rather than charged per visit.
- Eligibility
- Clinician-assessed at intake. SHED does not publish a BMI threshold or a list of states it serves.
- Provider involvement
- Licensed medical providers prescribe and manage treatment, and SHED names Dr Asad Niazi, MD publicly — better disclosure than most competitors. Unlimited follow-up appointments are included in the programme.
- Lab requirements
- Not published as a universal requirement.
- Pharmacy fulfillment
- Compounded medication from unnamed partner pharmacies; brand-name products through the usual manufacturer channels. SHED does not name its compounding pharmacy.
- Shipping frequency
- Monthly shipments. Note that the most serious complaints on its BBB record concern fulfilment — customers describing payments made for shipments that did not arrive.
- Support services
- Unusually generous: unlimited follow-up appointments, health coaching with text access, the Pivot GLP-1 tracking app, an online community, a nutrition plan and health courses, all included.
SHED Pricing
- Membership fee
- None stated. The medication price is presented as covering the programme, follow-ups and coaching.
- Medication fee
- SHED publishes compounded semaglutide "From $159/mo" and compounded tirzepatide "starting as low as $239/mo". It does not publish prices for its brand-name Wegovy and Zepbound pens, Foundayo, drops or lozenges. Third-party reporting quotes roughly $149/month for the oral Wegovy pill, $199/month for injections and the Wegovy pen, $299 for compounded semaglutide and $399 for compounded tirzepatide.
- Cancellation policy
- Not published. Confirm the terms and any notice requirement in writing before subscribing.
- Refund policy
- SHED advertises a money-back guarantee, but its own site states two different versions — "Lose 5% of your weight in 120 days or your money back" in one place and "Lose 10% of your body weight or your money back" in another. Those are materially different promises. Get the governing terms in writing before relying on either.
- Insurance
- Compounded medication is never covered. SHED does offer brand-name Wegovy and Zepbound, which insurance may cover, though it does not publish an insurance pathway. It confirms FSA eligibility for its GLP-1 products.
- HSA / FSA
- SHED states its GLP-1 and NAD+ products are FSA eligible. Confirm with your plan administrator.
Pricing details worth knowing
- Pricing reportedly escalates with dose. The "from" figure is a starter-dose price, and your bill at a maintenance dose is the number that matters.
- No published price for the brand-name pens, Foundayo, the drops or the lozenges, which is a large gap given how much of the range they represent.
- Third-party reported figures put compounded semaglutide at $299 — above the roughly $199 quoted for a brand-name Wegovy pen. If that holds at your dose, the FDA-approved option is the cheaper one, which is unusual and worth checking at checkout.
- SHED confirms FSA eligibility for its GLP-1 and NAD+ products, which many competitors leave unaddressed.
- Unlimited follow-up appointments, coaching, a tracking app and a nutrition plan are included rather than upsold.
Prices change. Every figure above was taken from SHED's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- The widest range of medications and formats in this comparison — compounded, brand-name, oral, drops, lozenges and microdose
- Offers Foundayo (orforglipron) and brand-name Wegovy and Zepbound alongside compounded options
- Unlimited follow-up appointments, coaching, tracking app and nutrition plan included at no extra charge
- Names a prescribing physician publicly, and is LegitScript-approved
- Trading since December 2022 with a reported 150,000-plus members and a strong Trustpilot score
- Confirms FSA eligibility, which most competitors do not address
Cons
- Dose-escalation pricing means your cost rises as you titrate — the advertised "from" figure is the least representative number
- No published price at all for the brand-name pens, Foundayo, drops or lozenges
- Two contradictory money-back guarantees appear on its own site (5% in 120 days versus 10%)
- BBB records a failure to respond to all 3 complaints filed against it
- Complaints allege paying for shipments that did not arrive — one customer describing 29 payments against 10 shipments
- Does not name its compounding pharmacy, publish a state list, or publish cancellation terms
Who SHED May Be Best For
People who do not yet know which format or molecule suits them and want the option to switch without changing provider
Anyone who wants a needle-free route — drops, lozenges or Foundayo — from a provider that also offers injections
Patients who value unlimited follow-ups and coaching being included rather than charged per visit
Limitations
Get your price at a maintenance dose, not a starter dose. On a dose-escalation model that is the only figure that tells you what a year costs.
If you are considering brand-name Wegovy or Zepbound here, ask for the price — none is published, and reporting suggests it may undercut the compounded option.
Establish in writing which money-back guarantee applies. The site states 5% in 120 days in one place and 10% in another, and those are not the same promise.
Check each shipment against what you have paid for. Fulfilment shortfalls are the substance of the complaints on its BBB record.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to SHED — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to SHED
bmiMD
The other wide-format provider, with sublingual tablets and a microdose plan, though also premium-priced
Read review →Mochi Health
Flat pricing at every dose — the direct answer to dose-escalation billing
Read review →NovoCare Pharmacy
FDA-approved Wegovy at a published $149/mo, with no from-pricing
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats SHED for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
How much does SHED cost?
SHED publishes "from" prices rather than a price list: compounded semaglutide "From $159/mo" and compounded tirzepatide "starting as low as $239/mo". It publishes nothing for its brand-name pens, Foundayo, drops or lozenges. Third-party reporting quotes roughly $149/month for the oral Wegovy pill, $199/month for injections and the Wegovy pen, $299 for compounded semaglutide and $399 for compounded tirzepatide, on a model where cost rises with dose. Ask what your maintenance dose will cost before enrolling.
Does SHED's price go up as my dose increases?
Reporting indicates yes — SHED uses a dose-escalation model, so the monthly cost rises as you titrate up. This is the most consequential thing to understand about its pricing, because almost everyone starts at a low dose and ends up at a higher one. A "from $159" quote at 0.25mg tells you very little about your bill at a maintenance dose six months later. Providers such as Mochi Health and Ondra Health hold price flat at every dose instead.
Which guarantee does SHED actually offer?
We cannot tell you, and that is the problem. Its site states "Lose 5% of your weight in 120 days or your money back" in one place and "Lose 10% of your body weight or your money back" in another. Those are materially different thresholds, and the second has no stated timeframe. If a guarantee is part of why you are signing up, get the governing terms confirmed in writing first.
Can I get brand-name Wegovy or Zepbound from SHED?
Yes — SHED is one of relatively few providers offering brand-name Wegovy and Zepbound pens and Foundayo (orforglipron) alongside compounded options. It does not publish prices for any of them, which is a real gap. Reporting suggests the brand-name pen may be cheaper than its compounded semaglutide at some doses, so it is worth asking for both figures rather than assuming compounded is the budget option.
Is SHED legitimate?
It is an established operation: trading since December 2022, LegitScript-approved, publicly naming a prescribing physician, with a reported 150,000-plus members and a solid Trustpilot score. Its BBB rating is B. The caveat is that the BBB records a failure to respond to all three complaints filed against it, and those complaints concern fulfilment — customers describing payments made for medication shipments that did not arrive. Three complaints is a small number for a company this size, but a 100% non-response rate is still a non-response rate.
Who should not use SHED?
Anyone who needs to know their cost in advance, particularly at a maintenance dose, and anyone who wants a published price for the specific product they intend to take. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis. Common side effects include nausea, vomiting, diarrhoea and constipation during titration. A licensed clinician who knows your history should decide.
The Verdict
SHED offers more routes to a GLP-1 than any provider we have reviewed: compounded semaglutide and tirzepatide, brand-name Wegovy and Zepbound, Foundayo, plus drops, lozenges and a microdose plan, with unlimited follow-ups and coaching included. The pricing is the problem — advertised as "from" figures on a dose-escalation model, so your cost rises as you titrate. Its site also states two different money-back guarantees.
Opens SHED's official site · Verify current pricing there
Compare Every Provider Side by Side
See how SHED stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from SHED's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where SHED does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- tryshed.com — compounded semaglutide "From $159/mo", compounded tirzepatide "starting as low as $239/mo", NAD+ from $144/mo; brand-name Wegovy and Zepbound pens, Foundayo (orforglipron), GLP-1 liquid drops, sublingual lozenges and a microdose plan all listed without published prices; unlimited follow-up appointments, health coaching, Pivot tracking app, nutrition plan and community included; FSA eligibility confirmed for GLP-1 and NAD+; prescriber named as Dr Asad Niazi, MD (checked August 7, 2026)
- tryshed.com — two differing money-back statements: "Lose 5% of your weight in 120 days or your money back" and "Lose 10% of your body weight or your money back"
- Better Business Bureau profile, Shed, 3401 N Thanksgiving Way, Lehi UT 84043 — rating B, not BBB accredited, business started 1 December 2022, file opened 23 April 2025, 3 complaints filed and 3 unanswered, with the stated reason "Failure to respond to 3 complaint(s) filed against business" (checked August 7, 2026)
- Third-party reporting: dose-escalation pricing model; roughly $149/month oral Wegovy pill, $199/month injections and Wegovy pen, $299 compounded semaglutide, $399 compounded tirzepatide; LegitScript approval; more than 150,000 members; Trustpilot around 4.6
- BBB complaint detail alleging fulfilment shortfalls, including one customer reporting 29 payments against 10 shipments received and another reporting 7 payments at $299 against 5 shipments
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.